KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Goodwill (2016 - 2023)

Emergent BioSolutions' Goodwill history spans 14 years, with the latest figure at $218.2 million for Q2 2023.

  • For Q2 2023, Goodwill fell 2.98% year-over-year to $218.2 million; the TTM value through Jun 2023 reached $218.2 million, down 2.98%, while the annual FY2022 figure was $218.2 million, 2.98% down from the prior year.
  • Goodwill reached $218.2 million in Q2 2023 per EBS's latest filing, roughly flat from $218.2 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $268.6 million in Q3 2019 to a low of $218.2 million in Q4 2022.
  • Average Goodwill over 5 years is $249.5 million, with a median of $266.4 million recorded in 2020.
  • Peak YoY movement for Goodwill: surged 446.71% in 2019, then decreased 15.67% in 2021.
  • A 5-year view of Goodwill shows it stood at $266.6 million in 2019, then increased by 0.04% to $266.7 million in 2020, then fell by 15.67% to $224.9 million in 2021, then decreased by 2.98% to $218.2 million in 2022, then changed by 0.0% to $218.2 million in 2023.
  • Per Business Quant, the three most recent readings for EBS's Goodwill are $218.2 million (Q2 2023), $218.2 million (Q1 2023), and $218.2 million (Q4 2022).